Literature DB >> 10886112

Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

S Talwar1, P F Downie, L L Ng, I B Squire.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10886112      PMCID： PMC2014959          DOI： 10.1046/j.1365-2125.2000.00232.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  42 in total

1.  Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population.

Authors:  T A McDonagh; C E Morrison; A Lawrence; I Ford; H Tunstall-Pedoe; J J McMurray; H J Dargie
Journal:  Lancet       Date:  1997-09-20       Impact factor: 79.321

Review 2.  The epidemiology of heart failure.

Authors:  M R Cowie; A Mosterd; D A Wood; J W Deckers; P A Poole-Wilson; G C Sutton; D E Grobbee
Journal:  Eur Heart J       Date:  1997-02       Impact factor: 29.983

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology.

Authors: 
Journal:  Eur Heart J       Date:  1995-06       Impact factor: 29.983

5.  Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction.

Authors:  A P Davie; C M Francis; M P Love; L Caruana; I R Starkey; T R Shaw; G R Sutherland; J J McMurray
Journal:  BMJ       Date:  1996-01-27

6.  Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction.

Authors:  D Darbar; N C Davidson; N Gillespie; A M Choy; C C Lang; Y Shyr; G P McNeill; T H Pringle; A D Struthers
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

7.  Predictive properties of serum-prostate-specific antigen testing in a community-based setting.

Authors:  S J Jacobsen; E J Bergstralh; H A Guess; S K Katusic; G G Klee; J E Oesterling; M M Lieber
Journal:  Arch Intern Med       Date:  1996-11-25

8.  Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide.

Authors:  T Omland; A Aakvaag; V V Bonarjee; K Caidahl; R T Lie; D W Nilsen; J A Sundsfjord; K Dickstein
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

9.  A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.

Authors: 
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

10.  The amino-terminal portion of pro-brain natriuretic peptide (Pro-BNP) circulates in human plasma.

Authors:  P J Hunt; T G Yandle; M G Nicholls; A M Richards; E A Espiner
Journal:  Biochem Biophys Res Commun       Date:  1995-09-25       Impact factor: 3.575
View more
  3 in total

1.  N-terminal pro-B-type naturetic peptide (NTBNP): so much promise and such a disappointment.

Authors:  Neil S Cherniack
Journal:  Sleep Breath       Date:  2008-03       Impact factor: 2.816

2.  Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.

Authors:  Sakir Arslan; Mustafa Kemal Erol; Engin Bozkurt; Mahmut Acikel; Fuat Gundogdu; Sebahattin Atesal; Huseyin Senocak
Journal:  Int J Cardiovasc Imaging       Date:  2006-12-14       Impact factor: 2.357

3.  N-Terminal-proBNP (NT-proBNP) as an indicator of cardiac dysfunction. A study in patients presenting with suspected cardiac disorders.

Authors:  G Hess; J Moecks; D Zdunek
Journal:  Z Kardiol       Date:  2005-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.